PDL Biopharma
PDLI
#8043
Rank
โ‚ฌ0.23 B
Marketcap
2,10ย โ‚ฌ
Share price
-8.52%
Change (1 day)
N/A
Change (1 year)

Revenue for PDL Biopharma (PDLI)

Revenue in 2020 (TTM): โ‚ฌ73.13 Million

According to PDL Biopharma 's latest financial reports the company's current revenue is โ‚ฌ68.57 Million. In 2018 the company made a revenue of โ‚ฌ0.16 Billion a decrease over the revenue in the year 2017 that were of โ‚ฌ0.25 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for PDL Biopharma from 2001 to 2020

Annual revenue

Year Revenue Change
2020 (TTM)โ‚ฌ73.13 M
2018โ‚ฌ0.16 B-35.24%
2017โ‚ฌ0.25 B41.34%
2016โ‚ฌ0.18 B-61.41%
2015โ‚ฌ0.47 B1.67%
2014โ‚ฌ0.46 B23.08%
2013โ‚ฌ0.37 B18.26%
2012โ‚ฌ0.31 B3.45%
2011โ‚ฌ0.30 B4.95%
2010โ‚ฌ0.29 B8.42%
2009โ‚ฌ0.27 B8.13%
2008โ‚ฌ0.25 B
2006โ‚ฌ0.35 B48.05%
2005โ‚ฌ0.23 B191.23%
2004โ‚ฌ81.67 M32.84%
2003โ‚ฌ61.48 M53.73%
2002โ‚ฌ39.99 M5.97%
2001โ‚ฌ37.74 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Compugen
CGEN
โ‚ฌ5.87 M-91.44%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
โ‚ฌ30.59 B 44,519.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
โ‚ฌ53.24 M-22.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ50.54 B 73,605.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚ฌ27.96 M-59.22%๐Ÿ‡บ๐Ÿ‡ธ USA